RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SciVision Biotech - Stock

SciVision Biotech Liabilities 2024

SciVision Biotech Liabilities

533.66 M TWD

Ticker

1786.TW

ISIN

TW0001786002

In 2024, SciVision Biotech's total liabilities amounted to 533.66 M TWD, a -9.13% difference from the 587.3 M TWD total liabilities in the previous year.

SciVision Biotech Aktienanalyse

What does SciVision Biotech do?

SciVision Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing SciVision Biotech's Liabilities

SciVision Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SciVision Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SciVision Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SciVision Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SciVision Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SciVision Biotech Stock

What is the level of liabilities of SciVision Biotech this year?

SciVision Biotech has a debt balance of 533.66 M TWD this year.

What were the liabilities of SciVision Biotech compared to the previous year?

The liabilities of SciVision Biotech have increased by -9.13% dropped compared to the previous year.

What are the consequences of high debt for investors of SciVision Biotech?

High liabilities can pose a risk for investors of SciVision Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in SciVision Biotech?

Low liabilities mean that SciVision Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of SciVision Biotech affect the company?

An increase in liabilities of SciVision Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of SciVision Biotech affect the company?

A decrease in the liabilities of SciVision Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of SciVision Biotech?

Some factors that can influence the liabilities of SciVision Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of SciVision Biotech so important for investors?

The liabilities of SciVision Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can SciVision Biotech take to modify the liabilities?

To change its liabilities, SciVision Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does SciVision Biotech pay?

Over the past 12 months, SciVision Biotech paid a dividend of 1.98 TWD . This corresponds to a dividend yield of about 1.49 %. For the coming 12 months, SciVision Biotech is expected to pay a dividend of 2.04 TWD.

What is the dividend yield of SciVision Biotech?

The current dividend yield of SciVision Biotech is 1.49 %.

When does SciVision Biotech pay dividends?

SciVision Biotech pays a quarterly dividend. This is distributed in the months of October, November, August, August.

How secure is the dividend of SciVision Biotech?

SciVision Biotech paid dividends every year for the past 8 years.

What is the dividend of SciVision Biotech?

For the upcoming 12 months, dividends amounting to 2.04 TWD are expected. This corresponds to a dividend yield of 1.53 %.

In which sector is SciVision Biotech located?

SciVision Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SciVision Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SciVision Biotech from 8/18/2023 amounting to 1.98 TWD, you needed to have the stock in your portfolio before the ex-date on 7/26/2023.

When did SciVision Biotech pay the last dividend?

The last dividend was paid out on 8/18/2023.

What was the dividend of SciVision Biotech in the year 2023?

In the year 2023, SciVision Biotech distributed 1.418 TWD as dividends.

In which currency does SciVision Biotech pay out the dividend?

The dividends of SciVision Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SciVision Biotech

Our stock analysis for SciVision Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciVision Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.